Q4 2021 Neoleukin Therapeutics Inc Earnings Call Transcript
Good afternoon, and thank you for joining us today for Neoleukin Therapeutics conference call. (Operator Instructions) As a reminder, today's conference call is being recorded. I would now like to turn the call over to Julie Rathbun, Communications for Neoleukin Therapeutics. Julie, Please go ahead.
Thank you. Good afternoon, and welcome to Neoleukin Therapeutics Year-End 2021 Conference Call. Joining me on the call today from Neoleukin are Jonathan Drachman, CEO; Priti Patel, CMO; and Sean Smith, Vice President, Finance. Today's call is being recorded. It will be available for replay on the Investor Relations section of the Neoleukin website approximately 2 hours after the call for at least 30 days.
Before we start, I'd like to remind you that today's call will include forward-looking statements based on current expectations. Such statements represent management's judgments, intentions, beliefs and expectations about future events, strategies, product candidates and operating
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |